How Has the Amniotic Products Market Size Evolved in Recent Years?
The amniotic products market has seen considerable growth due to a variety of factors.
•The market size of amniotic products has seen a significant expansion in the past few years. The market is projected to escalate from $0.99 billion in 2024 to $1.08 billion in 2025, with a compound annual growth rate (CAGR) of 9.0%.
The progression during the historical period can be linked to the escalating prevalence of burn injuries, a surge in the demand for regenerative medicine, an increase in the utilization of amniotic products for surgical wounds, heightened awareness of amniotic products as a potential treatment method, and the worldwide expansion of amniotic products.
What are the Market Size and Expected Growth Rates for the Amniotic Products Market?
The amniotic products market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for amniotic products is anticipated to experience robust expansion in the coming few years, reaching $1.52 billion in 2029 with a compound annual growth rate (CAGR) of 8.9%.
This progress during the projection term is due to factors such as an increased inclination towards non-invasive treatments by patients, heightened occurrence of chronic wounds, partnerships and collaborations, the effect of COVID-19, escalated cases of ophthalmic disorders, and a rise in healthcare spending. Key trends happening within this projected timeframe include ongoing advancements in product technology, high growth potential, regional dynamics, the repercussion of COVID-19 and an impending worldwide recession, an influx in the target patient demographic, and developing economies.
What Are The Essential Drivers Behind The Growth Of The Amniotic Products Market?
The amniotic products market is likely to experience growth due to an increase in trauma and accident cases. Trauma pertains to sudden physical injuries which are severe enough to require immediate medical attention, whereas accidents are unintentional harmful incidents like slip and fall, vehicle mishaps, or sports-related injuries. A third-degree burn wound is commonly treated with a complete skin excision, followed by the application of a hyper-dry human amniotic membrane dressing. To illustrate, Eurostats, the statistical office of the European Union based in Luxembourg, reported in April 2024 that there were 20,653 deaths caused by road traffic accidents in the EU in 2022. This marked a 4% increase from the 19,917 fatalities in 2021. As such, the escalating number of traumas and accident cases are fueling the need for amniotic products.
How Is The Global Amniotic Products Market Divided Into Key Segments?
The amniotic products market covered in this report is segmented –
1) By Type: Amniotic Membranes, Amniotic Suspensions
2) By Application: Wound Care, Orthopedics, Ophthalmology, Other Applications
3) By End-Use: Hospitals And Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Amniotic Membranes: Dehydrated Amniotic Membranes, Cryopreserved Amniotic Membranes
2) By Amniotic Suspensions: Liquid Amniotic Suspensions, Lyophilized Amniotic Suspensions
Pre-Book The Amniotic Products Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Amniotic Products Market?
A core trend witnessing an increase in acceptance in the amniotic products market is product innovation. To secure their market positions, leading firms in the amniotic product sector are focusing on producing innovative products. As an illustration, Versea Health Inc., an American company specializing in life science, introduced the Biovance 3L ocular tri-layer human amniotic membrane in November 2022. Products such as Biovance 3L and Biovance 3L Ocular, representing the tri-layer human amniotic membrane category, are offered in both disc and sheet versions, designed specifically for the surgical and ocular sectors. The allograft product Biovance 3L Ocular offers an extracellular matrix, acting as a biological covering membrane. During wound healing, the Biovance amniotic membrane functions as a protective layer and aids in tissue growth.
Who Are the Key Players in the Amniotic Products Market?
Major companies operating in the amniotic products market include:
• Stryker Corporation
• Smith & Nephew plc
• Integra LifeSciences Holdings Corporation
• Lucina BioSciences LLC
• Bioventus LLC
• Organogenesis Inc.
• MiMedx Group
• AlloSource
• Orthofix US LLC
• ACell Inc.
• Aziyo Biologics Inc.
• TissueTech Inc.
• Amino Technology LLC
• LifeCell International Pvt. Ltd.
• Tissue Regenix Group plc
• Aroa Biosurgery Limited
• Skye Biologics Inc.
• Celularity Inc.
• NuVision Biotherapies Ltd.
• VIVEX Biologics Inc.
• Genesis Biologics Inc.
• Applied Biologics LLC
• Next Biosciences
• Surgenex LLC
What are the Regional Insights into the Amniotic Products Market?
North America was the largest region in the amniotic products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
